
Two doses of the Pfizer-BioNTech COVID-19 vaccine provide a high level of protection for populations, a new study shows. The findings from Israel — the first nation to report national data on the vaccine — show that two doses provide more than 95% protection for people 16 and older against COVID-19 infection, hospitalization and death.… read on > read on >